Evidence map›Paper›PMID 29458411›Full record

ArticleAlzheimer's research & therapy2018

Genome-wide pleiotropy analysis of neuropathological traits related to Alzheimer's disease.

Jaeyoon Chung, Xiaoling Zhang, Mariet Allen, Xue Wang, Yiyi Ma, Gary Beecham, Thomas J Montine, Steven G Younkin, Dennis W Dickson, Todd E Golde and 11 more

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's research & therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Celebrating neuropathology's contributions to Alzheimer's Disease Research Centers.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  5. Article
  6. Article
  7. Key variants via the Alzheimer's Disease Sequencing Project whole genome sequence data.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Genome-Wide Pleiotropy Study Identifies Association ofJournal of clinical medicine · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 9 institutions in 1 country.

Jaeyoon ChungBioinformatics Graduate Program, Boston University, Boston, MA, USA.
Xiaoling ZhangDepartment of Medicine (Biomedical Genetics), Boston University School of Medicine, Boston, MA, USA.
Mariet AllenDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Xue WangDepartment of Health Sciences Research, Mayo Clinic, Jacksonville, FL, USA.
Yiyi MaDepartment of Medicine (Biomedical Genetics), Boston University School of Medicine, Boston, MA, USA.
Gary BeechamHussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA.
Thomas J MontineDepartment of Pathology, University of Washington, Seattle, WA, USA.
Steven G YounkinDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Dennis W DicksonDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Todd E GoldeCenter for Translational Research in Neurodegenerative Disease, McKnight Brain Institute, University of Florida, Gainesville, FL, USA.
Nathan D PriceInstitute for Systems Biology, University of Washington, Seattle, WA, USA.
Nilüfer Ertekin-TanerDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Kathryn L LunettaDepartment of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
Jesse MezDepartment of Neurology, Boston University School of Medicine, Boston, MA, USA.
Alzheimer’s Disease Genetics Consortium
Richard MayeuxDepartment of Neurology and Sergievsky Center, Columbia University, New York, NY, USA.
Jonathan L HainesDepartment of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, USA.
Margaret A Pericak-VanceHussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA.
Gerard SchellenbergDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Gyungah R JunDepartment of Medicine (Biomedical Genetics), Boston University School of Medicine, Boston, MA, USA.
Lindsay A FarrerBioinformatics Graduate Program, Boston University, Boston, MA, USA. farrer@bu.edu.
Boston University · USMayo Clinic in Florida · USUniversity of Miami · USUniversity of Washington · USCase Western Reserve University · USColumbia University · USUniversity of Florida · USUniversity of Pennsylvania · USWinnMed · US

Funding

National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)U24AG021886 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI TATIANA M. FOROUD · 2002 to 2026
$119.8M
Alzheimer's Disease Genetics ConsortiumU01AG032984 · NIA · UNIVERSITY OF PENNSYLVANIA · PI SCHELLENBERG, GERARD DAVID · 2009 to 2024
$60.4M
THE NIA GENETICS OF ALZHEIMER'S DISEASE DATA STORAGE SITEU24AG041689 · NIA · UNIVERSITY OF PENNSYLVANIA · PI LI-SAN WANG · 2012 to 2026
$42.3M
Research Education ComponentP30AG019610 · NIA · SUN HEALTH RESEARCH INSTITUTE · PI REIMAN, ERIC MICHAEL · 2001 to 2020
$32.5M
Neuropathology CoreP30AG013846 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI KOWALL, NEIL W. · 1996 to 2020
$29.1M
Integrating the exposome and methylome to inform brain molecular changes in ADRD across established diverse cohorts.U01AG046139 · NIA · UNIVERSITY OF FLORIDA · PI ERTEKIN-TANER, NILUFER, FUNK, CORY · 2013 to 2022
$24.6M
Integrative translational discovery of vascular risk factors in aging and dementiaRF1AG051504 · NIA · MAYO CLINIC JACKSONVILLE · PI BU, GUOJUN, ERTEKIN-TANER, NILUFER · 2015 to 2019
$9.8M
Alzheimer Disease Genetic Architecture in African AmericansR01AG048927 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Lindsay A. Farrer · 2015 to 2026
$8.4M
National Brain and Tissue Resource for Parkinson's Disease and Related DisordersU24NS072026 · NINDS · BANNER SUN HEALTH RESEARCH INSTITUTE · PI BEACH, THOMAS G · 2011 to 2015
$7.8M
Genome Wide associate analysis of Alzheimer's DiseaseRC2AG036528 · NIA · UNIVERSITY OF PENNSYLVANIA · PI SCHELLENBERG, GERARD DAVID · 2009 to 2010
$5.4M
Genomic and Biological Studies of APOE ε2 in Alzheimer DiseaseRF1AG057519 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI FARRER, LINDSAY A., JUN, GYUNGAH · 2017 to 2017
$2.4M
Gene discovery in PSP by transcriptome, neuropathology and sequence analysisR01NS080820 · NINDS · MAYO CLINIC JACKSONVILLE · PI ERTEKIN-TANER, NILUFER · 2013 to 2017
$1.8M
NIA NIH HHS K23 AG046377NIA NIH HHS P30 AG013846NIA NIH HHS P30 AG019610NIA NIH HHS R01 AG032990NIA NIH HHS R01 AG048927NIA NIH HHS R01-AG048927NIA NIH HHS RC2 AG036528NIA NIH HHS RC2-AG036528NIA NIH HHS RF1 AG051504NIA NIH HHS RF1 AG057519NIA NIH HHS U01 AG032984NIA NIH HHS U01-AG032984NIA NIH HHS U01 AG046139NIA NIH HHS U24 AG021886NIA NIH HHS U24 AG041689NINDS NIH HHS R01 NS080820NINDS NIH HHS U24 NS072026
6 · The paper itself

Abstract

backgroundSimultaneous consideration of two neuropathological traits related to Alzheimer's disease (AD) has not been attempted in a genome-wide association study.

methodsWe conducted genome-wide pleiotropy analyses using association summary statistics from the Beecham et al. study (PLoS Genet 10:e1004606, 2014) for AD-related neuropathological traits, including neuritic plaque (NP), neurofibrillary tangle (NFT), and cerebral amyloid angiopathy (CAA). Significant findings were further examined by expression quantitative trait locus and differentially expressed gene analyses in AD vs. control brains using gene expression data.

resultsGenome-wide significant pleiotropic associations were observed for the joint model of NP and NFT (NP + NFT) with the single-nucleotide polymorphism (SNP) rs34487851 upstream of C2orf40 (alias ECRG4, P = 2.4 × 10

conclusionsOur findings suggest that pleiotropy analysis is a useful approach to identifying novel genetic associations with complex diseases and their endophenotypes. Functional studies are needed to determine whether ECRG4 or HDAC9 is plausible as a therapeutic target.

Indexed as

Alzheimer DiseaseGenetic PleiotropyCerebral Amyloid AngiopathyFemaleGenome-Wide Association StudyHistone DeacetylasesHumansMaleMeta-Analysis as TopicNeoplasm ProteinsNeurofibrillary TanglesPlaque, AmyloidPolymorphism, Single NucleotideRepressor ProteinsTumor Suppressor ProteinsECRG4 protein, humanHDAC9 protein, humanHistone DeacetylasesNeoplasm ProteinsRepressor ProteinsTumor Suppressor ProteinsAlzheimer’s diseaseECRG4Genome-wide association studyHDAC9Neuropathological traitsPleiotropy analysis

Identifiers

PMID29458411
PMCPMC5819208
OpenAlexW2790702541

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.